argenx NV ADR (ARGX) financial statements

Healthcare · Biotechnology · Market cap $50.6B

argenx NV ADR reported revenue of $4.2B in fiscal 2025, up 112.8% a year over 7 years.

Net income was $1.3B and the operating margin 24.8%, against -381.0% in 2018.

Free cash flow was $574M.

The diluted share count rose 98% over the period (dilution).

Revenue and free cash flow

Fiscal years, $ billions.

-2024620182019202020212022202320242025RevenueFree cash flow
Embed this chart

Free to use in articles and newsletters with the source line. Paste this HTML:

Income statement

Fiscal years, from argenx NV ADR's 10-K filings with the SEC.

Fiscal year20182019202020212022202320242025
Revenue$21M$78M$41M$497M$10M$36M$2.3B$4.2B
Cost of revenue————$29M$118M$227M$451M
Gross profit————-$19M-$82M$2.0B$3.8B
Research and development$84M$221M$371M$581M$663M$859M$983M$1.4B
Selling, general and admin—$72M$172M$308M$472M$712M$1.1B$1.4B
Operating income-$82M-$199M-$478M-$349M-$720M-$425M-$22M$1.1B
Interest expense——$8M$5M$4M$906,000$2M$4M
Pre-tax income—-$176M-$605M-$400M-$729M-$304M$85M$1.3B
Income tax—$5M$3M$9M-$20M-$9M-$748M-$13M
Net income-$67M-$181M-$608M-$408M-$710M-$295M$833M$1.3B
EPS (diluted)—-$4.69-$13.40-$7.99-$13.05-$5.16$12.78$19.57
Diluted shares33M39M45M51M54M57M65M66M
Gross margin————-193.5%-231.6%89.9%89.4%
Operating margin-381.0%-253.5%-1158.1%-70.1%-7184.7%-1196.2%-1.0%24.8%
Net margin-310.2%-231.0%-1475.3%-82.1%-7077.5%-830.4%37.0%30.4%

Balance sheet

Fiscal years, from argenx NV ADR's 10-K filings with the SEC.

Fiscal year20182019202020212022202320242025
Cash and short-term investments$322M$372M$1.2B$1.3B$801M$2.0B$1.5B$3.5B
Receivables—$32M$7M$38M$276M$497M$904M$1.6B
Inventory——$25M$109M$228M$311M$407M$474M
Total current assets—$1.5B$2.1B$2.5B$2.8B$4.1B$4.9B$6.9B
Property, plant and equipment—$9M$12M$16M$16M$23M$44M$48M
Total assets—$1.6B$2.3B$2.9B$3.1B$4.5B$6.2B$8.7B
Total current liabilities—$180M$328M$301M$302M$423M$670M$1.3B
Total liabilities—$430M$605M$316M$321M$445M$704M$1.4B
Shareholders' equity$616M$1.2B$1.7B$2.5B$2.8B$4.1B$5.5B$7.3B
Net debt-$322M-$372M-$1.2B-$1.3B-$801M-$2.0B-$1.5B-$3.5B

Cash flow

Fiscal years, from argenx NV ADR's 10-K filings with the SEC.

Fiscal year20182019202020212022202320242025
Operating cash flow—$152M-$398M-$607M-$863M-$420M-$83M$685M
Capital spending—$47M$5M$121M$104M$44M$68M$112M
Free cash flow—$105M-$404M-$728M-$967M-$464M-$151M$574M
Stock-based compensation—$44M$97M$179M$157M$233M$235M$248M
Free cash flow margin—133.7%-978.6%-146.4%-9641.2%-1306.2%-6.7%13.5%
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ARGX.
Open ARGX in Investingly

Questions

What was argenx NV ADR's revenue in 2025?

$4.2B in fiscal 2025, from its 10-K filing.

How much free cash flow does argenx NV ADR generate?

$574M in fiscal 2025 (operating cash flow minus capital spending).

From argenx NV ADR's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.